|
1
|
World Health Organization (WHO): Global
cancer burden growing, amidst mounting need for services.
https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services#:~:text=Lung%20cancer%20was%20the%20leading,660%20000%20deaths%2C%206.8%25.
Accessed March 22, 2025.
|
|
2
|
Georgakopoulou VE, Lempesis IG, Trakas N,
Sklapani P, He Y and Spandidos DA: Lung cancer and obesity: A
contentious relationship (Review). Oncol Rep.
52(158)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Warren GW and Cummings KM: Tobacco and
lung cancer: Risks, trends, and outcomes in patients with cancer.
Am Soc Clin Oncol Educ Book. 33:359–364. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Trakas N, Georgakopoulou VE, Melemeni D,
Damaskos C, Mantzouranis K, Garmpis N, Gkoufa A, Papalexis P,
Chlapoutakis S, Sklapani P, et al: Association between smoking
cessation and alterations in forced expiratory volume in one second
(FEV1). A Follow-up study from a Greek Tobacco Cessation Clinic.
Addict Health. 14:87–95. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Volkow ND, Baler RD, Compton WM and Weiss
SR: Adverse health effects of marijuana use. N Engl J Med.
370:2219–2227. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Moir D, Rickert WS, Levasseur G, Larose Y,
Maertens R, White P and Desjardins S: A comparison of mainstream
and sidestream marijuana and tobacco cigarette smoke produced under
two machine smoking conditions. Chem Res Toxicol. 21:494–502.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Singh R, Sandhu J, Kaur B, Juren T,
Steward WP, Segerbäck D and Farmer PB: Evaluation of the DNA
damaging potential of cannabis cigarette smoke by the determination
of acetaldehyde derived N2-ethyl-2'-deoxyguanosine adducts. Chem
Res Toxicol. 22:1181–1188. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hashibe M, Morgenstern H, Cui Y, Tashkin
DP, Zhang ZF, Cozen W, Mack TM and Greenland S: Marijuana use and
the risk of lung and upper aerodigestive tract cancers: Results of
a population-based case-control study. Cancer Epidemiol Biomarkers
Prev. 15:1829–1834. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Aldington S, Williams M, Nowitz M,
Weatherall M, Pritchard A, McNaughton A, Robinson G and Beasley R:
Effects of cannabis on pulmonary structure, function and symptoms.
Thorax. 62:1058–1063. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Grassin-Delyle S, Naline E, Buenestado A,
Faisy C, Alvarez JC, Salvator H, Abrial C, Advenier C, Zemoura L
and Devillier P: Cannabinoids inhibit cholinergic contraction in
human airways through prejunctional CB1 receptors. Br J Pharmacol.
171:2767–2777. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tashkin DP, Coulson AH, Clark VA, Simmons
M, Bourque LB, Duann S, Spivey GH and Gong H: Respiratory symptoms
and lung function in habitual heavy smokers of marijuana alone,
smokers of marijuana and tobacco, smokers of tobacco alone, and
nonsmokers. Am Rev Respir Dis. 135:209–216. 1987.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Moore BA, Augustson EM, Moser RP and
Budney AJ: Respiratory effects of marijuana and tobacco use in a
U.S. sample. J Gen Intern Med. 20:33–37. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pletcher MJ, Vittinghoff E, Kalhan R,
Richman J, Safford M, Sidney S, Lin F and Kertesz S: Association
between marijuana exposure and pulmonary function over 20 years.
JAMA. 307:173–181. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bifulco M, Laezza C, Pisanti S and
Gazzerro P: Cannabinoids and cancer: Pros and cons of an antitumour
strategy. Br J Pharmacol. 148:123–135. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ladin DA, Soliman E, Griffin L and Van
Dross R: Preclinical and clinical assessment of cannabinoids as
Anti-cancer agents. Front Pharmacol. 7(361)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pacher P, Kogan NM and Mechoulam R: Beyond
THC and endocannabinoids. Annu Rev Pharmacol Toxicol. 60:637–659.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Andre CM, Hausman JF and Guerriero G:
Cannabis sativa: The plant of the thousand and one molecules. Front
Plant Sci. 7(19)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hill KP: Medical marijuana for treatment
of chronic pain and other medical and psychiatric problems: A
clinical review. JAMA. 313:2474–2483. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pertwee RG: The diverse CB1 and CB2
receptor pharmacology of three plant cannabinoids:
Delta9-tetrahydrocannabinol, cannabidiol and
delta9-tetrahydrocannabivarin. Br J Pharmacol. 153:199–215.
2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Carliner H, Brown QL, Sarvet AL and Hasin
DS: Cannabis use, attitudes, and legal status in the U.S.: A
review. Prev Med. 104:13–23. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dilley JA, Richardson SM, Kilmer B, Pacula
RL, Segawa MB and Cerdá M: Prevalence of cannabis use in youths
after legalization in washington state. JAMA Pediatr. 173:192–193.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hill KP, Gold MS, Nemeroff CB, McDonald W,
Grzenda A, Widge AS, Rodriguez C, Kraguljac NV, Krystal JH and
Carpenter LL: Risks and benefits of cannabis and cannabinoids in
psychiatry. Am J Psychiatry. 179:98–109. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hoch E, Volkow ND, Friemel CM, Lorenzetti
V, Freeman TP and Hall W: Cannabis, cannabinoids and health: A
review of evidence on risks and medical benefits. Eur Arch
Psychiatry Clin Neurosci. 275:281–292. 2025.PubMed/NCBI View Article : Google Scholar
|
|
24
|
National Academies of Sciences,
Engineering and Medicine; Health and Medicine Division; Board on
Population Health and Public Health Practice; Committee on the
Health Effects of Marijuana: An Evidence Review and Research
Agenda. The Health Effects of Cannabis and Cannabinoids: The
Current State of Evidence and Recommendations for Research.
Washington (DC), National Academies Press (US), Jan 12. 4, 2017.
Therapeutic Effects of Cannabis and Cannabinoids. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK425767/.
|
|
25
|
Whiting PF, Wolff RF, Deshpande S, Di
Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K,
Ryder S, et al: Cannabinoids for medical use: A systematic review
and Meta-analysis. JAMA. 313:2456–2473. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Machado Rocha FC, Stéfano SC, De Cássia
Haiek R, Rosa Oliveira LM and Da Silveira DX: Therapeutic use of
Cannabis sativa on chemotherapy-induced nausea and vomiting among
cancer patients: Systematic review and Meta-analysis. Eur J Cancer
Care (Engl). 17:431–443. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Badowski ME: A review of oral cannabinoids
and medical marijuana for the treatment of chemotherapy-induced
nausea and vomiting: A focus on pharmacokinetic variability and
pharmacodynamics. Cancer Chemother Pharmacol. 80:441–449.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Koppel BS, Brust JC, Fife T, Bronstein J,
Youssof S, Gronseth G and Gloss D: Systematic review: Efficacy and
safety of medical marijuana in selected neurologic disorders
[RETIRED]: Report of the Guideline development subcommittee of the
american academy of neurology. Neurology. 82:1556–1563.
2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Walsh Z, Gonzalez R, Crosby K, S Thiessen
M, Carroll C and Bonn-Miller MO: Medical cannabis and mental
health: A guided systematic review. Clin Psychol Rev. 51:15–29.
2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bonn-Miller MO, Boden MT, Bucossi MM and
Babson KA: Self-reported cannabis use characteristics, patterns and
helpfulness among medical cannabis users. Am J Drug Alcohol Abuse.
40:23–30. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Di Forti M, Marconi A, Carra E, Fraietta
S, Trotta A, Bonomo M, Bianconi F, Gardner-Sood P, O'Connor J,
Russo M, et al: Proportion of patients in south London with
first-episode psychosis attributable to use of high potency
cannabis: A case-control study. Lancet Psychiatry. 2:233–238.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tashkin DP: Effects of marijuana smoking
on the lung. Ann Am Thorac Soc. 10:239–247. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Thomas G, Kloner RA and Rezkalla S:
Adverse cardiovascular, cerebrovascular, and peripheral vascular
effects of marijuana inhalation: What cardiologists need to know.
Am J Cardiol. 113:187–190. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jouanjus E, Lapeyre-Mestre M and Micallef
J: French Association of the Regional Abuse and Dependence
Monitoring Centres (CEIP-A) Working Group on Cannabis
Complications*. Cannabis use: Signal of increasing risk of serious
cardiovascular disorders. J Am Heart Assoc.
3(e000638)2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gunn JK, Rosales CB, Center KE, Nuñez A,
Gibson SJ, Christ C and Ehiri JE: Prenatal exposure to cannabis and
maternal and child health outcomes: A systematic review and
Meta-analysis. BMJ Open. 6(e009986)2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Calapai F, Cardia L, Esposito E,
Ammendolia I, Mondello C, Lo Giudice R, Gangemi S, Calapai G and
Mannucci C: Pharmacological aspects and biological effects of
cannabigerol and its synthetic derivatives. Evid Based Complement
Alternat Med. 2022(3336516)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lu HC and Mackie K: An Introduction to the
endogenous cannabinoid system. Biol Psychiatry. 79:516–525.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Roque-Bravo R, Silva RS, Malheiro RF,
Carmo H, Carvalho F, da Silva DD and Silva JP: Synthetic
cannabinoids: A pharmacological and toxicological overview. Annu
Rev Pharmacol Toxicol. 63:187–209. 2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mills B, Yepes A and Nugent K: Synthetic
cannabinoids. Am J Med Sci. 350:59–62. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chayasirisobhon S: Mechanisms of action
and pharmacokinetics of cannabis. Perm J. 25:1–3. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Gonçalves J, Rosado T, Soares S, Simão AY,
Caramelo D, Luís Â, Fernández N, Barroso M, Gallardo E and Duarte
AP: Cannabis and Its secondary metabolites: Their use as
therapeutic drugs, toxicological aspects, and analytical
determination. Medicines (Basel). 6(31)2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zendulka O, Dovrtělová G, Nosková K,
Turjap M, Šulcová A, Hanuš L and Juřica J: Cannabinoids and
cytochrome P450 interactions. Curr Drug Metab. 17:206–226.
2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Long T, Wagner M, Demske D, Leipe C and
Tarasov PE: Cannabis in eurasia: Origin of human use and Bronze Age
trans-continental connections. Vegetation History and
Archaeobotany. 26:245–258. 2017.
|
|
44
|
Azofeifa A, Mattson ME, Schauer G, McAfee
T, Grant A and Lyerla R: National estimates of marijuana use and
related indicators-National survey on drug use and health, united
states, 2002-2014. MMWR Surveill Summ. 65:1–28. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Han BH, Sherman S, Mauro PM, Martins SS,
Rotenberg J and Palamar JJ: Demographic trends among older cannabis
users in the United States, 2006-13. Addiction. 112:516–525.
2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hasin DS, Saha TD, Kerridge BT, Goldstein
RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, et
al: Prevalence of marijuana use disorders in the united states
between 2001-2002 and 2012-2013. JAMA Psychiatry. 72:1235–1242.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Teesson M, Slade T, Swift W, Mills K,
Memedovic S, Mewton L, Grove R, Newton N and Hall W: Prevalence,
correlates and comorbidity of DSM-IV cannabis use and cannabis use
disorders in australia. Aust N Z J Psychiatry. 46:1182–1192.
2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hall W and Lynskey M: Assessing the public
health impacts of legalizing recreational cannabis use: The US
experience. World Psychiatr. 19:179–186. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mechoulam R and Parker LA: The
endocannabinoid system and the brain. Annu Rev Psychol. 64:21–47.
2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Di Marzo V and Piscitelli F: The
endocannabinoid system and its modulation by phytocannabinoids.
Neurotherapeutics. 12:692–698. 2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Howlett AC, Barth F, Bonner TI, Cabral G,
Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR,
et al: International union of pharmacology. XXVII. Classification
of cannabinoid receptors. Pharmacol Rev. 54:161–202.
2002.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Munro S, Thomas KL and Abu-Shaar M:
Molecular characterization of a peripheral receptor for
cannabinoids. Nature. 365:61–65. 1993.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Klein TW: Cannabinoid-based drugs as
anti-inflammatory therapeutics. Nat Rev Immunol. 5:400–411.
2005.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Morales P and Reggio PH: An update on
non-CB1, non-CB2 cannabinoid related G-Protein-coupled receptors.
Cannabis Cannabinoid Res. 2:265–273. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Garmpis N, Damaskos C, Dimitroulis D,
Garmpi A, Diamantis E, Sarantis P, Georgakopoulou VE, Patsouras A,
Prevezanos D, Syllaios A, et al: Targeting the endocannabinoid
system: From the need for new therapies to the development of a
promising strategy. What About Pancreatic Cancer? In Vivo.
36:543–555. 2022.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Velasco G, Sánchez C and Guzmán M:
Anticancer mechanisms of cannabinoids. Curr Oncol. 2
(Suppl):S23–S32. 2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
ElSohly MA, Mehmedic Z, Foster S, Gon C,
Chandra S and Church JC: Changes in cannabis potency over the last
2 decades (1995-2014): Analysis of current data in the united
states. Biological Psychiatry. 79:613–619. 2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Atakan Z: Cannabis, a complex plant:
Different compounds and different effects on individuals. Ther Adv
Psychopharmacol. 2:241–254. 2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Le Boisselier R, Alexandre J,
Lelong-Boulouard V and Debruyne D: Focus on cannabinoids and
synthetic cannabinoids. Clin Pharmacol Ther. 101:220–229.
2017.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Wilkie G, Sakr B and Rizack T: Medical
marijuana use in oncology: A review. JAMA Oncol. 2:670–675.
2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Hancock-Allen JB, Barker L, VanDyke M and
Holmes DB: Notes from the field: Death following ingestion of an
edible marijuana product-Colorado, March 2014. MMWR Morb Mortal
Wkly Rep. 64:771–772. 2015.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ghasemiesfe M, Ravi D, Vali M, Korenstein
D, Arjomandi M, Frank J, Austin PC and Keyhani S: Marijuana use,
respiratory symptoms, and pulmonary function: A systematic review
and Meta-analysis. Ann Intern Med. 169:106–115. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Biehl JR and Burnham EL: Cannabis smoking
in 2015: A concern for lung health? Chest. 148:596–606.
2015.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Kempker JA, Honig EG and Martin GS: The
effects of marijuana exposure on expiratory airflow. A study of
adults who participated in the U.S. National Health and Nutrition
Examination Study. Ann Am Thorac Soc. 12:135–141. 2015.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Baumeister SE, Baurecht H, Nolde M,
Alayash Z, Gläser S, Johansson M and Amos CI: International Lung
Cancer Consortium. Johnson EC and Hung RJ: Cannabis use, pulmonary
function, and lung cancer susceptibility: A mendelian randomization
study. J Thorac Oncol. 16:1127–1135. 2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Niu D, Li C, Qu H and Zheng Y: Does
cannabis elevate cancer risk?: Evidence from Mendelian
randomization. Wien Klin Wochenschr. 136:311–318. 2024.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Layden JE, Ghinai I, Pray I, Kimball A,
Layer M, Tenforde MW, Navon L, Hoots B, Salvatore PP, Elderbrook M,
et al: Pulmonary Illness Related to E-cigarette use in illinois and
wisconsin-final report. N Engl J Med. 382:903–916. 2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Maertens RM, White PA, Williams A and Yauk
CL: A global toxicogenomic analysis investigating the mechanistic
differences between tobacco and marijuana smoke condensates in
vitro. Toxicology. 308:60–73. 2013.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Barbers RG, Gong H Jr, Tashkin DP, Oishi J
and Wallace JM: Differential examination of bronchoalveolar lavage
cells in tobacco cigarette and marijuana smokers. Am Rev Respir
Dis. 135:1271–1275. 1987.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Roth MD and Baldwin GC: Mechanisms for
impaired effector function in alveolar macrophages from marijuana
and cocaine smokers. J Neuroimmunol. 147:82–86. 2004.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Sherman MP, Campbell LA, Gong H Jr, Roth
MD and Tashkin DP: Antimicrobial and respiratory burst
characteristics of pulmonary alveolar macrophages recovered from
smokers of marijuana alone, smokers of tobacco alone, smokers of
marijuana and tobacco and nonsmokers. Am Rev Respir Dis.
144:1351–1356. 1991.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Baldwin GC, Tashkin DP, Buckley DM, Park
AN, Dubinett SM and Roth MD: Marijuana and cocaine impair alveolar
macrophage function and cytokine production. Am J Respir Crit Care
Med. 156:1606–1613. 1997.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Roth MD, Baldwin GC and Tashkin DP:
Effects of delta-9-tetrahydrocannabinol on human immune function
and host defense. Chem Phys Lipids. 121:229–239. 2002.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Shay AH, Choi R, Whittaker K, Salehi K,
Kitchen CM, Tashkin DP, Roth MD and Baldwin GC: Impairment of
antimicrobial activity and nitric oxide production in alveolar
macrophages from smokers of marijuana and cocaine. J Infect Dis.
187:700–704. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
75
|
Yang X, Hegde VL, Rao R, Zhang J,
Nagarkatti PS and Nagarkatti M: Histone modifications are
associated with Δ9-tetrahydrocannabinol-mediated alterations in
antigen-specific T cell responses. J Biol Chem. 289:18707–18718.
2014.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Fligiel SE, Roth MD, Kleerup EC, Barsky
SH, Simmons MS and Tashkin DP: Tracheobronchial histopathology in
habitual smokers of cocaine, marijuana, and/or tobacco. Chest.
112:319–326. 1997.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Barsky SH, Roth MD, Kleerup EC, Simmons M
and Tashkin DP: Histopathologic and molecular alterations in
bronchial epithelium in habitual smokers of marijuana, cocaine
and/or tobacco. J Natl Cancer Inst. 90:1198–1200. 1998.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Gracie K and Hancox RJ: Cannabis use
disorder and the lungs. Addiction. 116:182–190. 2021.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Hancox RJ, Shin HH, Gray AR, Poulton R and
Sears MR: Effects of quitting cannabis on respiratory symptoms. Eur
Respir J. 46:80–87. 2015.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Tan C, Hatam N and Treasure T: Bullous
disease of the lung and cannabis smoking: Insufficient evidence for
a causative link. J R Soc Med. 99:77–80. 2006.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Bloom JW, Kaltenborn WT, Paoletti P,
Camilli A and Lebowitz MD: Respiratory effects of non-tobacco
cigarettes. Br Med J (Clin Res Ed). 295:1516–1518. 1987.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Tashkin DP, Simmons MS and Tseng CH:
Impact of changes in regular use of marijuana and/or tobacco on
chronic bronchitis. COPD. 9:367–374. 2012.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Murtha L, Sathiadoss P, Salameh JP,
Mcinnes MDF and Revah G: Chest CT Findings in Marijuana Smokers.
Radiology. 307(e212611)2023.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Aldington S, Harwood M, Cox B, Weatherall
M, Beckert L, Hansell A, Pritchard A, Robinson G and Beasley R:
Cannabis and respiratory disease research group. Cannabis use and
risk of lung cancer: A case-control study. Eur Respir J.
31:280–286. 2008.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Sidney S, Quesenberry CP, Friedman GD and
Tekawa IS: Marijuana use and cancer incidence (California, United
States). Cancer Causes Control. 8:722–728. 1997.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Voirin N, Berthiller J, Benhaïm-Luzon V,
Boniol M, Straif K, Ayoub WB, Ayed FB and Sasco AJ: Risk of lung
cancer and past use of cannabis in Tunisia. J Thorac Oncol.
1:577–579. 2006.PubMed/NCBI
|
|
87
|
Berthiller J, Straif K, Boniol M, Voirin
N, Benhaïm-Luzon V, Ayoub WB, Dari I, Laouamri S, Hamdi-Cherif M,
Bartal M, et al: Cannabis smoking and risk of lung cancer in men: A
pooled analysis of three studies in Maghreb. J Thorac Oncol.
3:1398–1403. 2008.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Callaghan RC, Allebeck P and Sidorchuk A:
Marijuana use and risk of lung cancer: A 40-year cohort study.
Cancer Causes Control. 24:1811–1820. 2013.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Hancox RJ, Poulton R, Ely M, Welch D,
Taylor DR, McLachlan CR, Greene JM, Moffitt TE, Caspi A and Sears
MR: Effects of cannabis on lung function: A population-based cohort
study. Eur Respir J. 35:42–47. 2010.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Wu TC, Tashkin DP, Djahed B and Rose JE:
Pulmonary hazards of smoking marijuana as compared with tobacco. N
Engl J Med. 318:347–351. 1988.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Sarafian TA, Habib N, Oldham M, Seeram N,
Lee RP, Lin L, Tashkin DP and Roth MD: Inhaled marijuana smoke
disrupts mitochondrial energetics in pulmonary epithelial cells in
vivo. Am J Physiol Lung Cell Mol Physiol. 290:L1202–L129.
2006.PubMed/NCBI View Article : Google Scholar
|
|
92
|
National Academies of Sciences,
Engineering and Medicine; Health and Medicine Division; Board on
Population Health and Public Health Practice; Committee on the
Health Effects of Marijuana: An Evidence Review and Research
Agenda. The Health Effects of Cannabis and Cannabinoids: The
Current State of Evidence and Recommendations for Research.
Washington (DC), National Academies Press (US), Jan 12. 7, 2017.
Respiratory Disease. Available from: https://www.ncbi.nlm.nih.gov/books/NBK425753/.
|
|
93
|
Hazzard AA, McCrorey M, Salman T, Johnson
DE, Luo Z, Fu X, Keegan AP, Benitez A, Fitting S and Jiang W:
Cannabis use, oral dysbiosis, and neurological disorders.
NeuroImmune Pharm Ther. 3:183–193. 2024.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Braymiller JL, Barrington-Trimis JL,
Leventhal AM, Islam T, Kechter A, Krueger EA, Cho J, Lanza I, Unger
JB and McConnell R: Assessment of nicotine and cannabis vaping and
respiratory symptoms in young adults. JAMA Netw Open.
3(e2030189)2020.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Joshi M, Joshi A and Bartter T: Marijuana
and lung diseases. Curr Opin Pulm Med. 20:173–179. 2014.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Gates P, Jaffe A and Copeland J: Cannabis
smoking and respiratory health: Consideration of the literature.
Respirology. 19:655–662. 2014.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Martinasek MP, McGrogan JB and Maysonet A:
A systematic review of the respiratory effects of inhalational
marijuana. Respir Care. 61:1543–1551. 2016.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Jett J, Stone E, Warren G and Cummings KM:
Cannabis use, lung cancer, and related issues. J Thorac Oncol.
13:480–407. 2018.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Ghasemiesfe M, Barrow B, Leonard S,
Keyhani S and Korenstein D: Association between marijuana use and
risk of cancer: A systematic review and meta-analysis. JAMA Netw
Open. 2(e1916318)2019.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Clark TM: Scoping review and meta-analysis
suggests that cannabis use may reduce cancer risk in the United
States. Cannabis Cannabinoid Res. 6:413–34. 2021.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Nigro E, Formato M, Crescente G and
Daniele A: Cancer initiation, progression and resistance: Are
phytocannabinoids from Cannabis sativa L. promising compounds?
Molecules. 26(2668)2021.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Kaplan AG: Cannabis and lung health: Does
the bad outweigh the good? Pulm Ther. 7:395–408. 2021.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Joshi M, Joshi A and Bartter T: Marijuana
and the lung: Evolving understandings. Med Clin North Am.
106:1093–1107. 2022.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Khoj L, Zagà V, Amram DL, Hosein K,
Pistone G, Bisconti M, Serafini A, Cammarata LM, Cattaruzza MS and
Mura M: Effects of cannabis smoking on the respiratory system: A
state-of-the-art review. Respir Med. 221(107494)2024.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Nargis N, Westmaas JL, Orr E, Alqahtani
MM, Choudhury PP, Islami F and Jemal A: Cancer risk and
legalisation of access to cannabis in the USA: overview of the
evidence. Lancet Public Health. 10:e160–e164. 2025.PubMed/NCBI View Article : Google Scholar
|
